We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zendesk Acquires FutureSimple to Ease Salesforce Automation
Read MoreHide Full Article
Zendesk Inc. recently announced that it acquired FutureSimple Inc. — provider of the well-known customer relationship management and sales productivity platform called Base.
Base provides “sales force automation software” aimed at optimizing efficiency of the sales workforce. Being an easy to use mobile application, it is widely used by a large number of companies.
Last year, the duo, Base and Zendesk, had already partnered when they launched an integrated version of their products. Hence the old partners are expected to perform even better now, as they will operate under the same umbrella.
Presently, Base has offices located in San Francisco and Krakow, Poland and around 5000 customers worldwide. While the customers will continue enjoying services even after the acquisition, the talent pool of Base will be absorbed by Zendesk.
As a result, Zendesk’s top line is anticipated to witness a significant improvement moving ahead. In second-quarter 2018, the company’s revenues surged 39% from the year-ago quarter to $141.9 million better than the Zacks Consensus Estimate of $138 million.
Zendesk is gaining momentum backed by strong adoption of the company’s products. Increasing usage of its products by existing customers is also driving growth.
During the last reported quarter, the company launched the Zendesk Suite — its new omnichannel bundle — which brings together Support, Guide, Talk, and Chat products. It also launched Zendesk Connect that enables proactive customer engagement.
Zendesk continued to add features to its enterprise products as well. Moreover, the company launched new enterprise workflow and collaboration tools during the same period.
The company's customer base expanded in the quarter with new additions like Henry Schein, IDEX, Netflix (NFLX - Free Report) and Yandex Taxi, among others.
However, the company’s margins were slightly under pressure due to the ongoing transition from co-located data centers to cloud infrastructure. Nevertheless, Zendesk expects to complete the transition by 2018 end, which might help the company post better financials in the long run.
Long-term growth rate for Five9 and Paycom Software is pegged at 20% and 25.5%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Zendesk Acquires FutureSimple to Ease Salesforce Automation
Zendesk Inc. recently announced that it acquired FutureSimple Inc. — provider of the well-known customer relationship management and sales productivity platform called Base.
Base provides “sales force automation software” aimed at optimizing efficiency of the sales workforce. Being an easy to use mobile application, it is widely used by a large number of companies.
Last year, the duo, Base and Zendesk, had already partnered when they launched an integrated version of their products. Hence the old partners are expected to perform even better now, as they will operate under the same umbrella.
Presently, Base has offices located in San Francisco and Krakow, Poland and around 5000 customers worldwide. While the customers will continue enjoying services even after the acquisition, the talent pool of Base will be absorbed by Zendesk.
As a result, Zendesk’s top line is anticipated to witness a significant improvement moving ahead. In second-quarter 2018, the company’s revenues surged 39% from the year-ago quarter to $141.9 million better than the Zacks Consensus Estimate of $138 million.
Zendesk, Inc. Revenue (TTM)
Zendesk, Inc. Revenue (TTM) | Zendesk, Inc. Quote
Zendesk’s Overall Performance
Zendesk is gaining momentum backed by strong adoption of the company’s products. Increasing usage of its products by existing customers is also driving growth.
During the last reported quarter, the company launched the Zendesk Suite — its new omnichannel bundle — which brings together Support, Guide, Talk, and Chat products. It also launched Zendesk Connect that enables proactive customer engagement.
Zendesk continued to add features to its enterprise products as well. Moreover, the company launched new enterprise workflow and collaboration tools during the same period.
The company's customer base expanded in the quarter with new additions like Henry Schein, IDEX, Netflix (NFLX - Free Report) and Yandex Taxi, among others.
However, the company’s margins were slightly under pressure due to the ongoing transition from co-located data centers to cloud infrastructure. Nevertheless, Zendesk expects to complete the transition by 2018 end, which might help the company post better financials in the long run.
Zacks Rank & Key Picks
Currently, Zendesk has a Zacks Rank #3 (Hold).
Five9, Inc. (FIVN - Free Report) and Paycom Software, Inc. (PAYC - Free Report) are stocks worth considering in the same sector as both sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term growth rate for Five9 and Paycom Software is pegged at 20% and 25.5%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>